ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

NRXS Neuraxis Inc

2,70
-0,10 (-3,57%)
20 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Neuraxis Inc NRXS AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,10 -3,57% 2,70 22:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,85 2,50 2,90 2,70 2,80
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/6/202415:00GLOBENeurAxis Announces New Submission to the FDA for the..
22/5/202414:00GLOBENeurAxis Reports First Quarter 2024 Financial Results
21/5/202415:00GLOBENeurAxis to Participate in the Lytham Partners Spring 2024..
20/5/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/5/202415:00GLOBENeurAxis Announces New Medical Policy Coverage For Nearly..
15/5/202422:30GLOBENeurAxis to Host First Quarter 2024 Results and Business..
15/5/202422:15EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
23/4/202415:00GLOBENeurAxis Announces New Medical Policy Coverage in North..
09/4/202422:05GLOBENeurAxis Reports Fourth Quarter and Fiscal Year 2023..
01/4/202422:15GLOBENeurAxis to Host Fourth Quarter and Full Year 2023 Results..
27/3/202414:00GLOBENeurAxis Announces IB-Stim Results from a Large, Pediatric,..
11/3/202414:00GLOBENeurAxis Announces Highmark BCBS Policy Coverage
11/3/202413:50EDGAR2Form 8-K - Current report
04/3/202415:00GLOBENeurAxis Announces Blue Cross and Blue Shield of Kansas City..
27/2/202417:00GLOBENeurAxis to Present at Oppenheimer 34th Annual Healthcare..
15/2/202423:00EDGAR2Form 8-K - Current report
31/1/202415:15EDGAR2Form 8-K - Current report
20/12/202315:00GLOBENeurAxis, Inc. Issues Letter to Shareholders from Brian..
19/12/202323:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202323:00EDGAR2Form 8-K - Current report
20/11/202323:30GLOBENeurAxis Reports Third Quarter 2023 Financial Results
20/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202315:00GLOBENeurAxis Announces CareFirst BCBS Policy Coverage
14/11/202315:00GLOBENeurAxis Secures $3 Million Financing
08/11/202315:00GLOBENeurAxis Signs Exclusive Option Agreement with University of..
26/9/202315:00GLOBENeurAxis Announces Results of Comparative Study of IB-Stim™..
22/9/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/9/202314:30EDGAR2Form 8-K - Current report
21/9/202314:00GLOBENeurAxis Reports Second Quarter 2023 Financial Results
13/9/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/9/202315:00GLOBENeurAxis to Present at the Gilmartin Group Emerging Growth..
12/9/202315:00GLOBENeurAxis Announces Publication of Prospective Study Showing..
29/8/202317:49APSNews Brief: NeurAxis Inc.
29/8/202315:00GLOBENeurAxis Highlights Pediatric Post-Concussion Clinical Study
24/8/202315:00GLOBENeurAxis Highlights Strength of its Board of Directors
22/8/202315:00GLOBENeurAxis Highlights Two Independent Studies Showing Benefits..
17/8/202315:02GLOBENeurAxis Announces Over $8 Million in IB-Stim™ Revenue
10/8/202315:00GLOBEExchange Listing Client, Neuraxis, Inc., Successfully..